Expert opinion
- Watch our virtual roundtable discussion to learn from medical experts
- Explore the unmet needs for pain management in patients with OA
- Investigate the patient-centred approach to OA pain management
Chair Professor David Walsh introduces the roundtable discussion, which aims to help develop physician beliefs and behaviours in line with current guidelines in order to build on the patient-centred approach to osteoarthritis (OA) pain management.
Professor Walsh begins by introducing himself and his fellow faculty.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Professor Walsh poses questions to the faculty around personalised pain management for patients with OA,
along with pain assessment and the risk/benefit considerations of treatment.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Professor Walsh invites the faculty’s opinion on the current guidelines, the importance of exercise,
whether to use drug combinations and common misconceptions in treating OA pain.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Given the previously discussed limitation of current treatments, Professor Walsh
questions the faculty on emerging therapies for OA pain.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Professor Walsh closes the roundtable and thanks his fellow faculty. People with OA pain have suffered enough and while there are new and emerging treatments that hold much potential,
more people can also gain much more benefit from existing treatments if we use a personalised and holistic approach.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Put your knowledge of osteoarthritis-related pain to the test with this interactive quiz based on our recent virtual roundtable meeting, including:
- considerations when treating osteoarthritis
- the effectiveness of combination therapy
- the response in terms of pain and function to regular exercise
- tolerability of NSAIDs
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
References
- Birbara C, Dabezies EJ, Burr AM, Fountaine RJ, Smith MD, Brown MT, et al. Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis. J Pain Res. 2018;11:151–164.
- Dakin P, DiMartino SJ, Gao H, Maloney J, Kivitz AJ, Schnitzler TJ et al. The efficacy, tolerability, and joint safety of fasinumab in osteoarthritis pain: A phase IIb/III double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheumatol. 2019;71(11):1824–1834.
2. Dakin P, DiMartino SJ, Gao H, Maloney J, Kivitz AJ, Schnitzler TJ et al. The efficacy, tolerability, and joint safety of fasinumab in osteoarthritis pain: A phase IIb/III double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheumatol. 2019;71(11):1824–1834.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
of interest
are looking at
saved
next event
This content has been developed independently by Medthority who previously received educational funding in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.